Jaeb Center for Health Research
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Jaeb Center for Health Research sits in the top decile of US sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count).
Jaeb Center for Health Research: 119 sponsored US clinical trials, 17 recruiting.
Jaeb Center for Health Research sponsors 119 registered US clinical trials on ClinicalTrials.gov, 17 of them currently recruiting, and 89 completed. 53 of these trials are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Amblyopia, with 9 trials.
Top-decile sponsor footprint
Jaeb Center for Health Research ranks in the top decile of sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
89 of 95 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
119 total, page 3 of 3
Correction of Myopia Evaluation Trial 2
NCT00320593
Study of Surgical Procedures for Treatment of Persistent Nasolacrimal Duct Obstruction in Children < 4 Years Old
NCT00315315
Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years Old
NCT00315302
Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old
NCT00315198
Study of Primary Surgical Treatment of Nasolacrimal Duct Obstruction in Children Less Than Four Years Old
NCT00315289
Bilateral Refractive Amblyopia Treatment Study
NCT00305955
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
NCT00367133
Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes
NCT00109434
An Observational Study of Infantile, Acquired Non-accommodative, and Acquired Partially-accommodative Esotropia
NCT00310960
Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children
NCT00091923
Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer
NCT00069628
Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children
NCT00069615
An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old
NCT00094692
Assessing Continuous Glucose Monitors in Healthy Children
NCT00069602
Trial Comparing Daily Atropine Versus Weekend Atropine
NCT00094614
Continuous Glucose Monitors for Children With Diabetes Mellitus
NCT00069537
Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia
NCT00094744
Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia
NCT00094679
Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia
NCT00000170
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 18 |
| Phase 3 | 46 |
| Phase 4 | 7 |
Where Jaeb Center for Health Research enrollment is open (later-stage tilt)
17 recruiting of 119 indexed (14% open); 89 completed (75%).
Phase mix: 53 late (III/IV) vs 21 early (I/II) (later-stage heavy).
Top condition: Amblyopia (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Jaeb Center for Health Research: open-pipeline peers nationwide
Peers matched on 119 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Jaeb Center for Health Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 119 trials (± recruiting share)
- Children's Hospital Los Angeles · 119 trials · 29% recruiting
- Medtronic - MITG · 119 trials · 4% recruiting
- Michigan State University · 120 trials · 20% recruiting
- San Diego State University · 118 trials · 27% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Jaeb Center for Health Research page
119 registered trials is a research-attention snapshot, not an endorsement of Jaeb Center for Health Research or any single study.
- 17 of Jaeb Center for Health Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Amblyopia is the condition Jaeb Center for Health Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Amblyopia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Jaeb Center for Health Research pipeline card: 119 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.